Comparer des méthodes

	Indice de Qualité de Vie en Dermatologie	Questionnaire sur la maladie de Parkinson-39
Domaine	Résultats de santé	Résultats de santé
Famille	Process / pipeline	Process / pipeline
Année d'origine	1994	1997
Auteur d'origine	Andrew Y. Finlay and Gul K. Khan	Crispin Jenkinson et al.
Type	Self-report quality of life questionnaire	Self-report quality of life questionnaire
Source fondatrice	Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19(3), 210-216.	Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997). The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score. Age and Ageing, 26(5), 353-357.
Alias	DLQI, Finlay Index, Dermatology Quality of Life	PDQ-39, Parkinson's Disease Questionnaire, PDQ
Apparentées	3	4
Résumé	The DLQI is the primary patient-centered outcome measure in dermatology research and clinical practice. Developed by Andrew Finlay and Gul Khan in 1994, this 10-item self-report questionnaire quantifies the impact of skin disease on patients' daily functioning, emotional well-being, social relationships, and work capacity. It is simple, rapid, and applicable to virtually all dermatological conditions, making it the gold standard for assessing quality of life in dermatology.	The PDQ-39 is the most widely used patient-reported outcome measure for Parkinson's disease quality of life. Developed by Crispin Jenkinson and colleagues in 1997, this 39-item self-report questionnaire comprehensively assesses how Parkinson's symptoms affect daily functioning, emotional well-being, stigma, social support, and cognitive-communication abilities. It is the recommended instrument in major Parkinson's disease clinical trials and forms a core component of outcome measurement in movement disorders.